CMBA
WST icon

C.M. Bidwell & Associates’s West Pharmaceutical WST Stock Holding History

C.M. Bidwell & Associates’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-620
Closed -$255K – 568
2022
Q1 		$255K Sell
620
-304
-33% -$119K 0.17% 115
2021
Q4 		$433K Sell
924
-23
-2% -$9.9K 0.27% 60
2021
Q3 		$402K Sell
947
-280
-23% -$118K 0.27% 59
2021
Q2 		$441K Buy
1,227
+76
+7% +$25.1K 0.29% 54
2021
Q1 		$324K Buy
1,151
+3
+0.3% +$859 0.24% 63
2020
Q4 		$325K Sell
1,148
-122
-10% -$34.2K 0.27% 56
2020
Q3 		$349K Buy
1,270
+631
+99% +$167K 0.32% 51
2020
Q2 		$145K Buy
+639
New +$126K 0.13% 164

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return